MAY REFERENCES

MAY REFERENCES

"FIGHTING NOSOCOMIAL PNEUMONIA," BY JOHN ROARK, PAGE 14

1. Mandell LA. Douglas G. Chest. 1998; 113:188S-193S; March 1998.

2. Joseph P. Iii Lynch. Hospital-acquired pneumonia: risk factors,microbiology and treatment. Feb, 2001

3. Author uncredited. One hospital's early intervention slashed pneumoniarates. RN. July 2002.

Fagon J-Y, Chastre J, Hance AJ, et al. Detection of nosocomial lung infectionin ventilated patients: use of a protected specimen brush and quantitativeculture techniques in 147 patients. Am Rev Respir Dis. 1988; 138:110-116.

4. Bowton DL. Nosocomial pneumonia in the ICU: year 2000 and beyond. March1999

"STERILIZATION UNWRAPPED," BY BECKI HARTER, PAGE 26

1. Reichert, Marimargaret and Young, Jack, H. (1997). SterilizationTechnology (second edition). MaRYLAND, Gaithersburg: Aspen

2. Sherman, ax (1998). Medical Device Packaging Handbook (second edition).New York: Basel. Marcel Dekker, Inc.

3. AAMI ST33

4. AAMI TIR 12 Premarket Notification 510(k): Regulatory Requirement forMedical Devices. Center for Devices and Radiological Health, Department ofHealth and Human Services.

5. IAHCSMM, Central Service Technical Manual (fifth edition), revisedexpanded, IAHCSMM (1998), Chicago, Ill.

"TAKING CONTROL OF AIRBORNE AND WATERBORNE DISEASES," BY JOHNROARK, PAGE 30

1. Noble S. Nosocomial infections altering purchasing patterns, practices.Healthcare Purchasing News Dec. 2001.

2. Streifel AJ and Hendrickson C. Assessment of health risks related toconstruction. HPAC Engineering. Feb. 2002.

3. Muscarella LF. Disinfecting endoscopes immediately before the firstpatient of the day. AORN Journal. June 2001

"STRICTER PRECAUTIONS, ACTIVE SURVEILLANCE CAN BEAT MRSA AND VRE,"BY KELLY M. PYREK, PAGE 34

1. Farr BM, Salgado CD, Karchmer TB, Sherertz RJ. Can antibiotic-resistantnosocomial infections be controlled? Lancet Infect Dis. 2001 Aug;1(1):38-45.

2. Farr BM. MRSA and VRE: Is It Important to Control the Reservoir? WebberTraining teleclass, March 12, 2003. www.webbertraining.com

3. MultiResistant Organisms module. Occupational Safety and HealthAdministration. www.osha.gov

4. Karchmer TB, Durbin LJ, Simonton BM and Farr BM. Cost-effectiveness ofactive surveillance cultures and contact/droplet precautions for the control ofmethicillin resistant staphylococcus aureus. J Hosp Infection. Vol. 51 Issue 2,June 2002, pp. 126-132.

5. Muto CA, Giannetta ET, Durbin LJ, Simonton BM, Farr BM. Cost-effectivenessof perirectal surveillance cultures for controlling vancomycin-resistantenterococcus. Infect Control Hosp Epidemiol. 2002 Aug;23(8):429-35.

6. Farr BM. Methicillin-resistant Staphylococcus aureus infections. CurrInfect Dis Rep. 1999 Oct;1(4):328-333.

7. Christensen A, Scheel O, Urwitz K, Bergh K. Outbreak of methicillin-resistantStaphylococcus aureus in a Norwegian hospital. Department of Microbiology,Buskerud Central Hospital, Drammen, Norway. Scand J Infect Dis.2001;33(9):663-6.

8. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistantStaphylococcus aureus: a meta-analysis of prevalence and risk factors.University of Virginia Health System. Clin Infect Dis. 2003 Jan 15;36(2):131-9.

"WHAT'S LURKING IN YOUR ENDOSCOPE?" BY KATHY DIX, PAGE 44

1. Alvarado C, Reichelderfer M -- The 1997, 1998 and 1999 APIC GuidelinesCommittees. APIC Guideline for Infection Prevention and Control in FlexibleEndoscopy. AJIC Am J Infect Control 2000;28:138-55.

2. Muscarella L. Going Back to School. Q-Net Monthly 2003;3-4:5-8.